0.25% Bupivacaine Hcl Injection, Solution
Product Images NDC 51662-1606

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for 0.25% Bupivacaine Hcl (NDC 51662-1606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1396 2 Pouch Labeling

Label for 0.5% Bupivacaine Hydrochloride Injection, USP 250 mg/50 mL (5 mg/mL) in a 50 mL vial. The label includes the NDC number 51662-1396-2, lot number 123456, and expiration date 2025-01-01. It indicates the product is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, and is for nerve block use only. Storage instructions and aseptic technique reminders are also included.*

FDA Label Image

51662139622 Bupivacaine Pouch Label

Label for 0.5% Bupivacaine Hydrochloride Injection, USP, showing strength 250 mg/50 mL (5 mg/mL) in a 50 mL vial. The label includes the NDC number 51662-1396-2, lot number 12345, and expiration date 2001-03-01. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

51662139639 Bupivacaine Case Label

Label for 0.5% Bupivacaine Hydrochloride Injection, 5 mg/mL strength in a 50 mL vial, box of 25. Includes NDC 51662-1396-3, lot number 12345, and expiration date January 1, 2030. Manufactured by HF Acquisition Co LLC, Mukilteo, WA, for human prescription use.*

FDA Label Image

51662139639 Bupivacaine Rfid Label

0.25% BUPIVACAINE HCl injection solution label containing a GS1 DataMatrix barcode, lot number, expiration date, and unique identifiers. The label includes distribution information for HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. The text advises to see the manufacturer's package insert and indicates the product is Rx only.*

FDA Label Image

Description 1 (Description 1)

A table showing concentration levels of Bupivacaine Hydrochloride and Sodium Chloride. Concentrations include 0.25%, 0.50%, and 0.75%, with corresponding Bupivacaine Hydrochloride amounts of 2.5, 5, and 7.5 mg/mL, and Sodium Chloride amounts of 8.6, 8.1, and 7.6 mg/mL respectively.*

FDA Label Image

Description 2 (Description 2)

A data table showing concentrations of Bupivacaine HCl in three formulations: 0.25%, 0.50%, and 0.75%. It lists corresponding Bupivacaine Hydrochloride amounts in mg/mL (2.5, 5, 7.5), Epinephrine 1:200,000 concentration in mcg/mL (5 for all), and Sodium Chloride concentration in mg/mL (8.5 for all).*

FDA Label Image

Dosage And Administration (Dosage And Administration)

A data table showing dosage information per type of nerve block for Bupivacaine HCl injections. It lists block types like local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and epidural test dose, with corresponding concentrations, dose volumes, mg amounts, and motor block effects.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table presenting various units of sale and concentration details for BUPIVACAINE HCl injection, solution. The table lists NDC codes, vial types (single-dose Teartop and multiple-dose Fliptop vials), vial counts of 25 per tray, concentration percentages ranging from 0.25% to 0.75%, and specific drug amounts per vial volume along with pH ranges of 4.0 to 6.5 for each formulation.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing the unit of sale and concentration details for 0.25% and 0.50% BUPIVACAINE HCl injection solutions. It includes NDC numbers, packaging configurations such as cartons and trays of single-dose teartop vials, and cases of multiple-dose fliptop vials, along with strength in mg/mL and pH range of 3.3 to 5.5.*

FDA Label Image

Indications And Usage (Indications And Usage)

A data table listing various uses of Bupivacaine HCl with corresponding concentration percentages. It includes local infiltration at 0.25%, peripheral nerve block at 0.25% and 0.5%, retrobulbar block at 0.75%, sympathetic block at 0.25%, lumbar epidural at 0.25%, 0.5%, and 0.75% (with a note that 0.75% is not for obstetrical anesthesia), caudal at 0.25% and 0.5%, epidural test dose at 0.5% with epinephrine 1:200,000, and dental blocks at 0.5% with epinephrine 1:200,000.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A data table listing drug classes and examples, including Nitrates/Nitrites (e.g., nitric oxide, nitroglycerin), Local anesthetics (e.g., bupivacaine, lidocaine), Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with corresponding examples in each class.*

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

0.5% Bupivacaine Hydrochloride Injection, USP in a multiple-use fliptop vial with a green cap. The label indicates a 50 mL vial containing 250 mg/50 mL (5 mg/mL). The product is for nerve block and is distributed by HF Acquisition Co., LLC, Mukilteo, WA. The vial includes a barcode, lot number, and expiration details.*

FDA Label Image

Structure 1 (Structure 1)

Chemical structure diagram of 0.25% BUPIVACAINE HCl showing the molecular components including a piperidine ring, an amide linkage, a substituted aromatic ring with two methyl groups, and hydration and hydrochloride components.*

FDA Label Image

Structure 2 (Structure 2)

Chemical structure of 0.25% Bupivacaine HCl shown as a molecular diagram with functional groups and bonds depicted.*

FDA Label Image

Vial Label (Vial Label)

Label for 0.5% Bupivacaine Hydrochloride Injection, USP, a multiple-dose fliptop vial containing 250 mg/50 mL (5 mg/mL). The label highlights use for nerve block and indicates it is not for caudal, epidural, or spinal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. The label includes drug content, preservatives, storage conditions, and lot/expiration placeholders.*

FDA Label Image

Boxed Warning (Warnings)

A text panel discussing the risks associated with the 0.75% concentration of bupivacaine hydrochloride. It notes that this concentration is not recommended for obstetrical anesthesia due to reports of cardiac arrest and difficult resuscitation. The panel advises that the 0.75% concentration should be reserved for surgical procedures requiring a high degree of muscle relaxation and prolonged effect.*

FDA Label Image

Logo (How Supplied Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.